Previously, when the isotope tracer approach was applied, it pinpointed that NAFLD patients produced elevated glucose concentration (hepatic insulin resistance) and lower glucose uptake (peripheral insulin resistance) in spite of increased insulin levels in comparison to the healthy subjects (49). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.